Prakt. lékáren. 2012; 8(1): 12-14

Use of products with 40% urea in onychomycosis treatment

Magdalena Skořepová
Dermatovenerologická klinika 1. LF UK a VFN v Praze

Chemical nail avulsion using 40% urea ointment is an additional method in the treatment of onychomycosis. It allows painless removal

of the affected nail plate and enhances the effectivity of topical and systemic antifungal therapy. It is suitable and safe for children,

pregnant women and elderly patients.

Keywords: chemical nail avulsion, onychomycosis, 40% urea ointment

Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skořepová M. Use of products with 40% urea in onychomycosis treatment. Praktické lékárenství. 2012;8(1):12-14.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 2010; 35(5): 497-519. Go to original source... Go to PubMed...
    2. Baran R, Hay RJ, Garduno JI. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. J Dermatolog Treat 2008; 19(2): 72-81. Go to original source... Go to PubMed...
    3. Baran R, Hay RJ, Garduno JI. Review of antifungal therapy, part II: treatment rationale, including specific patient populations. J Dermatolog Treat 2008; 19(3): 168-175. Go to original source... Go to PubMed...
    4. Farber EM, South DA. Urea ointment in the nonsurgical avulsion of nail dystrophies. Cutis 1978; 22(6): 689-692. Go to PubMed...
    5. Moncada B, Loredo CE, Isordia E. Treatment of onychomycosis with ketoconazole and nonsurgical avulsion of the affected nail. Cutis 1983; 31(4): 438-440. Go to PubMed...
    6. Nolting S. Non-traumatic removal of the nail and simultaneous treatment of onychomycosis. Dermatologica 1984; 169(Suppl. 1): 117-120. Go to original source... Go to PubMed...
    7. Hardjoko FS, Widyanto S, Singgih I, Susilo J. Treatment of onychomycosis with a bifonazole-urea combination. Mycoses 1990; 33(4): 167-171. Go to original source... Go to PubMed...
    8. Torres-Rodríguez JM, Madrenys N, Nicolás MC. Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole. Mycoses 1991; 34(11-12): 499-504. Go to original source... Go to PubMed...
    9. Fritsch H, Stettendorf S, Hegemann L. Ultrastructural changes in onychomycosis during the treatment with bifonazole/ urea ointment. Dermatology 1992; 185(1): 32-36. Go to original source... Go to PubMed...
    10. Gunt HB, Kasting GB. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur J Pharm Sci 2007; 32(4-5): 254-260. Go to original source... Go to PubMed...
    11. Bonifaz A, Ibarra G. Onychomycosis in children: treatment with bifonazole-urea. Pediatr Dermatol 2000; 17(4): 310-314. Go to original source... Go to PubMed...
    12. Loo DS. Onychomycosis in the elderly: drug treatment options. Drugs Aging 2007; 24(4): 293-302. Go to original source... Go to PubMed...
    13. ##
    14. Skořepová M. Použití přípravků s 40% ureou v léčbě onychomykóz. Prakt. lékáren. 2012; 8(1): 12-14.
    15. Sklenář Z. Magistraliter receptura v dermatologii. Praha: Galén 2009: 262.
    16. Sklenář Z. Močovina - vlastnosti, použití a praktické zapracování do topických polotuhých základů. Prakt. lékáren. 2007; 3(4): 177-180.
    17. Hašek J, Sklenář Z. Nové léčivé látky v magistraliter receptuře III - klotrimazol. Prakt. lékáren. 2010; 6(5): 244-249.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.